Landkind Announces Preliminary Results from ISTO Clinical Study Showing LK-01™ Pure Salidroside Supports Oxygen Uptake and Mood state
05. Januar 2023 09:00 ET
|
DoubleRainbow Biosciences
LEXINGTON, MASS., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Landkind, a subsidiary of DoubleRainbow Biosciences leveraging advances in synthetic biology to deliver precision-engineered supplements to...
Landkind reaches significant regulatory milestone, achieving GRAS status for LK-01™ Pure Salidroside
19. Dezember 2022 08:00 ET
|
DoubleRainbow Biosciences
LEXINGTON, MASS., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Landkind, a subsidiary of DoubleRainbow Biosciences leveraging advances in synthetic biology to deliver precision-engineered supplements to...
Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications
28. November 2022 09:41 ET
|
DoubleRainbow Biosciences
Lexington, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health,...
DoubleRainbow Biosciences Announces Strategic AI Collaboration with Galixir
07. November 2022 08:10 ET
|
DoubleRainbow Biosciences
LEXINGTON, MASS., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Double Rainbow, a sustainable health care company harnessing the power of natural evolution through bioengineering to improve the quality of human...
DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4
25. Oktober 2022 09:25 ET
|
DoubleRainbow Biosciences
LEXINGTON, MASS. and LAS VEGAS, NEV., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Landkind, a subsidiary of Double Rainbow Biosciences leveraging advances in synthetic biology to deliver precision-engineered...
DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics
22. August 2022 10:40 ET
|
DoubleRainbow Biosciences
Lexington, MA, Aug. 22, 2022 (GLOBE NEWSWIRE) -- DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health,...